Target intelligence / Profile preview

Nectin cell adhesion molecule 2 (NECTIN2)

Target
NECTIN2
Molecular classification
Cell adhesion molecule, Immunoglobulin superfamily (IgSF), Single-pass type I membrane glycoprotein
01

Overview

Nectin cell adhesion molecule 2 (NECTIN2), also known as Nectin-2 or CD112, is a single-pass type I membrane glycoprotein belonging to the immunoglobulin superfamily (IgSF)[1][2]. It is involved in calcium-independent cell–cell adhesion by forming both homophilic and heterophilic interactions, particularly in adherens junctions of fibroblasts, epithelial cells, and synaptic junctions of neurons[1][2]. The extracellular domain contains three Ig-like domains, with the N-terminal variable-type Ig-V domain mediating binding specificity[1]. NECTIN2 interacts with cytoplasmic afadin to link adherens junctions to the actin cytoskeleton[1][2]. Originally named for its role as a herpesvirus entry mediator (Herpesvirus entry mediator B), NECTIN2 also interacts with immune receptors such as DNAM-1 (CD226) and TIGIT, mediating immune cell–tumor cell interactions. Altered NECTIN2 expression is implicated in cancer progression, immune evasion, and viral infections[2].

Other names
Nectin-2CD112Herpesvirus entry mediator BHveBPRR2PVRL2PVRR2poliovirus receptor-like 2poliovirus receptor-related 2herpesvirus entry protein B
02

Biological functions

Cell–cell adhesion (homophilic and heterophilic)Formation of adherens junctionsImmune modulationSynaptic junction formationInteraction with cytoskeleton via afadin
03

Disease associations

CancerInfection (especially viral, e.g. herpesvirus entry)Immune-related disorders
04

Safety considerations

Potential for immune-related adverse events if targeted in immunotherapyDisruption of normal cell adhesion/junctions may have developmental or tissue integrity consequences
05

Biomarkers

CD112 expression (in immuno-oncology, for T/NK cell interaction studies)May be used in tumor diagnostics as a marker for certain tumors

Beyond the preview

Go deeper on Nectin cell adhesion molecule 2 (NECTIN2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Nectin cell adhesion molecule 2 (NECTIN2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call